Annual report pursuant to Section 13 and 15(d)

Segment Reporting (Tables)

v3.22.0.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment The tables below present financial information for the Company’s two operating business segments.
Year Ended December 31,
2021 2020
Revenues:
Corporate clinics $ 44,348,234  $ 31,757,207 
Franchise operations 36,511,419  26,925,769 
Total revenues $ 80,859,653  $ 58,682,976 
Depreciation and amortization:
Corporate clinics $ 5,446,663  $ 2,503,181 
Franchise operations 334,945  — 
Corporate administration 307,339  231,281 
Total depreciation and amortization $ 6,088,947  $ 2,734,462 
Segment operating income:
Corporate clinics $ 4,432,872  $ 4,508,990 
Franchise operations 16,706,643  12,561,278 
Total segment operating income $ 21,139,515  $ 17,070,268 
Reconciliation of total segment operating income to consolidated earnings before income taxes:
Total segment operating income $ 21,139,515  $ 17,070,268 
Unallocated corporate (15,787,096) (11,578,138)
Consolidated income from operations 5,352,419  5,492,130 
Bargain purchase gain —  — 
Other (expense), net (69,878) (79,478)
Income before income tax expense $ 5,282,541  $ 5,412,652 
Schedule of Reconciliation of Assets from Segment to Consolidated
December 31, 2021 December 31, 2020
Segment assets:
Corporate clinics $ 40,722,898  $ 24,928,311 
Franchise operations 12,593,912  9,957,097 
Total segment assets $ 53,316,810  $ 34,885,408 
(As Revised)
Unallocated cash and cash equivalents and restricted cash $ 19,912,338  $ 20,819,629 
Unallocated property and equipment 857,176  1,063,815 
Other unallocated assets 11,367,885  9,110,515 
Total assets $ 85,454,209  $ 65,879,367